"","Year","Diagnoses/Case","Estimate","Min.","1st Qu.","Median","Mean","3rd Qu.","Max."
"1",2010,"PLWHA","PLWHA",NA,NA,NA,2934.8,NA,NA
"6",2010,"Base Case","Undiagnosed Cases",603.5,605.1,606.3,606.1,607.3,608.5
"26",2010,"Base Case","True Prevalence",3538.2,3539.8,3541.1,3540.8,3542.1,3543.2
"46",2010,"Base Case","Undiagnosed Fraction (%)",17.1,17.1,17.1,17.1,17.1,17.2
"7",2010,"Base Case using Stage","Undiagnosed Cases",603.5,605.1,606.3,606.1,607.3,608.5
"27",2010,"Base Case using Stage","True Prevalence",3538.2,3539.8,3541.1,3540.8,3542.1,3543.2
"47",2010,"Base Case using Stage","Undiagnosed Fraction (%)",17.1,17.1,17.1,17.1,17.1,17.2
"9",2010,"Upper Bound","Undiagnosed Cases",1142,1147,1153,1152,1158,1161
"29",2010,"Upper Bound","True Prevalence",4076.8,4081.8,4087.8,4086.8,4092.8,4095.8
"49",2010,"Upper Bound","Undiagnosed Fraction (%)",28,28.1,28.2,28.2,28.3,28.3
"8",2010,"Upper Bound using Stage","Undiagnosed Cases",1142,1147,1153,1152,1158,1161
"28",2010,"Upper Bound using Stage","True Prevalence",4076.8,4081.8,4087.8,4086.8,4092.8,4095.8
"48",2010,"Upper Bound using Stage","Undiagnosed Fraction (%)",28,28.1,28.2,28.2,28.3,28.3
"2",2011,"PLWHA","PLWHA",NA,NA,NA,2936.2,NA,NA
"10",2011,"Base Case","Undiagnosed Cases",594.7,597.9,599.7,598.8,600.6,601.3
"30",2011,"Base Case","True Prevalence",3530.9,3534.2,3535.9,3535.1,3536.8,3537.6
"50",2011,"Base Case","Undiagnosed Fraction (%)",16.8,16.9,17,16.9,17,17
"11",2011,"Base Case using Stage","Undiagnosed Cases",594.7,597.9,599.7,598.8,600.6,601.3
"31",2011,"Base Case using Stage","True Prevalence",3530.9,3534.2,3535.9,3535.1,3536.8,3537.6
"51",2011,"Base Case using Stage","Undiagnosed Fraction (%)",16.8,16.9,17,16.9,17,17
"12",2011,"Upper Bound","Undiagnosed Cases",1114,1122,1126,1125,1129,1134
"32",2011,"Upper Bound","True Prevalence",4050.2,4058.2,4062.2,4061.2,4065.2,4070.2
"52",2011,"Upper Bound","Undiagnosed Fraction (%)",27.5,27.6,27.7,27.7,27.8,27.9
"13",2011,"Upper Bound using Stage","Undiagnosed Cases",1114,1122,1126,1125,1129,1134
"33",2011,"Upper Bound using Stage","True Prevalence",4050.2,4058.2,4062.2,4061.2,4065.2,4070.2
"53",2011,"Upper Bound using Stage","Undiagnosed Fraction (%)",27.5,27.6,27.7,27.7,27.8,27.9
"3",2012,"PLWHA","PLWHA",NA,NA,NA,2975,NA,NA
"15",2012,"Base Case","Undiagnosed Cases",561.7,563.6,567,569.6,573,582.6
"35",2012,"Base Case","True Prevalence",3536.7,3538.6,3542,3544.6,3548,3557.6
"55",2012,"Base Case","Undiagnosed Fraction (%)",15.9,15.9,16,16.1,16.1,16.4
"16",2012,"Base Case using Stage","Undiagnosed Cases",561.7,563.6,567,569.6,573,582.6
"36",2012,"Base Case using Stage","True Prevalence",3536.7,3538.6,3542,3544.6,3548,3557.6
"56",2012,"Base Case using Stage","Undiagnosed Fraction (%)",15.9,15.9,16,16.1,16.1,16.4
"14",2012,"Upper Bound","Undiagnosed Cases",1075,1077,1081,1084,1088,1099
"34",2012,"Upper Bound","True Prevalence",4050,4052,4056,4059,4063,4074
"54",2012,"Upper Bound","Undiagnosed Fraction (%)",26.5,26.6,26.7,26.7,26.8,27
"17",2012,"Upper Bound using Stage","Undiagnosed Cases",1075,1077,1081,1084,1088,1099
"37",2012,"Upper Bound using Stage","True Prevalence",4050,4052,4056,4059,4063,4074
"57",2012,"Upper Bound using Stage","Undiagnosed Fraction (%)",26.5,26.6,26.7,26.7,26.8,27
"4",2013,"PLWHA","PLWHA",NA,NA,NA,3070,NA,NA
"20",2013,"Base Case","Undiagnosed Cases",554.6,555.8,558.7,559.3,562.2,565.4
"40",2013,"Base Case","True Prevalence",3624.6,3625.8,3628.7,3629.3,3632.2,3635.4
"60",2013,"Base Case","Undiagnosed Fraction (%)",15.3,15.3,15.4,15.4,15.5,15.6
"18",2013,"Base Case using Stage","Undiagnosed Cases",554.6,555.8,558.7,559.3,562.2,565.4
"38",2013,"Base Case using Stage","True Prevalence",3624.6,3625.8,3628.7,3629.3,3632.2,3635.4
"58",2013,"Base Case using Stage","Undiagnosed Fraction (%)",15.3,15.3,15.4,15.4,15.5,15.6
"19",2013,"Upper Bound","Undiagnosed Cases",1068,1069,1071,1072,1075,1079
"39",2013,"Upper Bound","True Prevalence",4138,4139,4141,4142,4145,4149
"59",2013,"Upper Bound","Undiagnosed Fraction (%)",25.8,25.8,25.9,25.9,25.9,26
"21",2013,"Upper Bound using Stage","Undiagnosed Cases",1068,1069,1071,1072,1075,1079
"41",2013,"Upper Bound using Stage","True Prevalence",4138,4139,4141,4142,4145,4149
"61",2013,"Upper Bound using Stage","Undiagnosed Fraction (%)",25.8,25.8,25.9,25.9,25.9,26
"5",2014,"PLWHA","PLWHA",NA,NA,NA,3172.8,NA,NA
"22",2014,"Base Case","Undiagnosed Cases",544.4,548,552.9,551.8,556.6,557
"42",2014,"Base Case","True Prevalence",3717.2,3720.8,3725.7,3724.6,3729.3,3729.8
"62",2014,"Base Case","Undiagnosed Fraction (%)",14.6,14.7,14.8,14.8,14.9,14.9
"23",2014,"Base Case using Stage","Undiagnosed Cases",544.4,548,552.9,551.8,556.6,557
"43",2014,"Base Case using Stage","True Prevalence",3717.2,3720.8,3725.7,3724.6,3729.3,3729.8
"63",2014,"Base Case using Stage","Undiagnosed Fraction (%)",14.6,14.7,14.8,14.8,14.9,14.9
"24",2014,"Upper Bound","Undiagnosed Cases",1055,1059,1064,1063,1069,1070
"44",2014,"Upper Bound","True Prevalence",4227.8,4231.8,4236.8,4235.8,4241.8,4242.8
"64",2014,"Upper Bound","Undiagnosed Fraction (%)",25,25,25.1,25.1,25.2,25.2
"25",2014,"Upper Bound using Stage","Undiagnosed Cases",1055,1059,1064,1063,1069,1070
"45",2014,"Upper Bound using Stage","True Prevalence",4227.8,4231.8,4236.8,4235.8,4241.8,4242.8
"65",2014,"Upper Bound using Stage","Undiagnosed Fraction (%)",25,25,25.1,25.1,25.2,25.2
